PVI
Pura Vida Investments Portfolio holdings
AUM
$16.6M
This Quarter Return
-1.19%
1 Year Return
-3.82%
3 Year Return
-0.02%
5 Year Return
+29.84%
10 Year Return
+256.58%
AUM
$828M
AUM Growth
+$828M
(-14%)
Cap. Flow
-$45M
Cap. Flow
% of AUM
-5.44%
Top 10 Holdings %
Top 10 Hldgs %
49.76%
Holding
264
New
28
Increased
49
Reduced
25
Closed
53
Top Buys
| 1 |
Biogen
BIIB
|
$31M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
$15.5M |
| 3 |
C4 Therapeutics
CCCC
|
$14.4M |
| 4 |
Bio-Techne
TECH
|
$10.8M |
| 5 |
AMRS
Amyris Inc.
AMRS
|
$10.7M |
Top Sells
| 1 |
Natera
NTRA
|
$22M |
| 2 |
The Beauty Health Co
SKIN
|
$14.4M |
| 3 |
DexCom
DXCM
|
$14.1M |
| 4 |
ICU Medical
ICUI
|
$13.9M |
| 5 |
LivaNova
LIVN
|
$12.9M |
Sector Composition
| 1 | Healthcare | 89.68% |
| 2 | Materials | 1.3% |
| 3 | Industrials | 0.61% |
| 4 | Consumer Discretionary | 0.26% |
| 5 | Financials | 0.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CUTR
1
DELISTED
Cutera, Inc.
CUTR
| $74.1M | 2.4% | 1,074,151 -41,260 | -4% | -$2.85M |
|
2
Establishment Labs
ESTA
$1.2B
| $64.9M | 2.1% | 962,494 -163,704 | -15% | -$11M |
|
|
VRAY
3
DELISTED
ViewRay, Inc.
VRAY
| $53.2M | 1.72% | 13,561,808 -545,052 | -4% | -$2.14M |
|
4
Inspire Medical Systems
INSP
$2.77B
| $52.2M | 1.69% | 203,442 -11,000 | -5% | -$2.82M |
|
|
NSTG
5
DELISTED
NanoString Technologies, Inc.
NSTG
| $42.4M | 1.38% | 1,220,332 +36,772 | +3% | +$1.28M |
|
|
6
Biogen
BIIB
$19.4B
| $31M | 1% | +147,135 | New | +$31M |
|
|
7
LivaNova
LIVN
$3.08B
| $28.4M | 0.92% | 347,498 -157,269 | -31% | -$12.9M |
|
8
AtriCure
ATRC
$1.84B
| $22.1M | 0.72% | 336,615 -39,516 | -11% | -$2.6M |
|
|
9
Vertex Pharmaceuticals
VRTX
$100B
| $21.9M | 0.71% | 84,057 +59,421 | +241% | +$15.5M |
|
10
Outset Medical
OM
$247M
| $21.6M | 0.7% | 474,901 +21,698 | +5% | +$985K |
|
|
SLGC
11
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
| $19.9M | 0.64% | 2,475,815 -9,600 | -0.4% | -$77K |
|
|
IMDX
12
Insight Molecular Diagnostics Inc. Common Stock
IMDX
$72.4M
| $18.2M | 0.59% | 12,223,953 | – | – |
|
13
STAAR Surgical
STAA
$1.36B
| $15.7M | 0.51% | 196,074 +35,100 | +22% | +$2.8M |
|
|
14
C4 Therapeutics
CCCC
$185M
| $15.2M | 0.49% | 624,860 +595,616 | +2,037% | +$14.4M |
|
15
Pulmonx
LUNG
$69.7M
| $14.6M | 0.47% | 589,722 +109,634 | +23% | +$2.72M |
|
|
ISEE
16
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $14.6M | 0.47% | 865,144 -24,310 | -3% | -$409K |
|
17
BioMarin Pharmaceuticals
BMRN
$11.2B
| $13.5M | 0.44% | 175,356 +5,146 | +3% | +$397K |
|
|
18
ICU Medical
ICUI
$3.15B
| $12.8M | 0.42% | 57,700 -62,276 | -52% | -$13.9M |
|
19
Lantheus
LNTH
$3.73B
| $12.3M | 0.4% | 222,238 -73,457 | -25% | -$4.06M |
|
|
QTNT
20
DELISTED
Quotient Limited Ordinary Shares
QTNT
| $12.2M | 0.4% | 10,157,408 +1,506,991 | +17% | +$1.81M |
|
|
CNVY
21
DELISTED
Convey Health Solutions Holdings, Inc.
CNVY
| $11.3M | 0.37% | 1,720,752 +244,674 | +17% | +$1.6M |
|
|
22
Bio-Techne
TECH
$8.5B
| $10.8M | 0.35% | +25,000 | New | +$10.8M |
|
|
AMRS
23
DELISTED
Amyris Inc.
AMRS
| $10.7M | 0.35% | +2,461,436 | New | +$10.7M |
|
24
Codexis
CDXS
$246M
| $9.61M | 0.31% | 465,902 +2,800 | +0.6% | +$57.7K |
|
25
Bioventus
BVS
$495M
| $7.84M | 0.25% | 555,910 +3,700 | +0.7% | +$52.2K |
|